Prevalence of the metabolic syndrome in the mestizo population of Peru

Metabolic Syndrome and Related Disorders

Volumn 4, Issue 1, 2006, Pages 1-6

  Seclén, Segundo ^a   Villena, Arturo ^a   Martínez Larrad, María Teresa ^a   Gamarra, Dante ^b   Herrera, Bernabé ^c   Fernandez Pérez, Cristina ^b   González Sánchez, José Luis ^b   Serrano Ríos, Manuel ^b   dell Valle, Valerie ^d   Medina, Nancy ^d   Santos, Rosa ^d   Pérez Barba, Milagros ^d  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c MINISTERIO DE SALUD   (Peru)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DISEASE SURVEILLANCE; ETHNIC DIFFERENCE; FEMALE; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; OBESITY; PERU; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; URBAN POPULATION;

EID: 33646196655     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2006.4.1     Document Type: Article

References (26)

1. Alexander CM, Landsman PB, Teutsch SM, Haffner SM, Third National Health and Nutrition Examination Survey (NHANES III), National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52:1210-1214.
2. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
3. National Statistics and Information Institute of Peru [On-line]. Available at: . Accessed January 3, 2006.
4. Seclen S, La Diabetes Mellitus como Problema de Salud Publica en el Peru, 2nd ed. Uniersidad Peruana Cayetano Heredia: Ediciones New Graf, 2000.
5. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res 1998;6:51S-209S.
6. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167.
7. Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Brown EG, Turner RC. Continuous infusion of glucose with model assessment: measurement of insulin resitance and beta-cell function in man. Diabetologia, 1985;28:401-411.
8. Serrano Rios M, Ascaso Gimilio JF, Blazquez Fernandez E, Cabezas Cerraro J, Carmena Rodriguez R, Oscobar Jimenez F, Fernandez-Real JM, Gabriel Sanchez R, Gomis de Barbera R, Grande Aragon C, Herrera Pomba JL, Pallardo Sanchez LF, Potau Vilalta N, Ricart Engel W, Rovira Loscos A, Zorzano Olarte A, Grupo de Trabajo Resistencia a la insulina de la Sociedad Espanola de Diabetes. [Insulin resistance and its involvement in multiple risk factors associated with type 2 diabetes mellitus] [in Spanish]. Med Clin (Barc) 2002;119:458-463.
9. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA, Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol, 2002;156:1070-1077.
10. Ford ES, Giles WH, Dietz WH, Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
11. Alvarez Leon EE, Ribas Barba L, Serra Majem L, [Prevalence of the metabolic syndrome in the population of Canary Islands, Spain] [in Spanish]. Med Clin (Barc) 2003;120:172-174.
12. Bonora E, Kiechl S, Willeit J, et al. Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord 2003;27:1283-1289.
13. Villegas A, Botero JF, Arango IC, Arias S, Toro MM, Bol Asoc Latinoam Diabetes 2004;12:20-24.
14. Martínez J, Alvarenga M, Reyes J, Prevalencia del síndrome metabólico en una Comunidad Hondureña. Bol Asoc Latinoam Diabetes 2004;12:25-30.
15. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson P, Hedblad B. European Group for the Study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002;28:364-376.
16. Tan CE, Ma S, Wai D, Chew SK, Tai ES, Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004;27:1182-1186.
17. Seclén S, Leey L, Villena A, et al. Prevalencia de obesidad, diabetes mellitus, hipertensión arterial e hipercolesterolemia como factores de riesgo coronario y cerebrovascular en población adulta de la costa y selva del Peru. Acta Med Peruana, 1999;17:18-23.
18. Braguinsky J, Obesity prevalence in Latin America [On-line]. Available at: . Accessed October 5, 2002.
19. Lindgarde F, Soderberg S, Olsson T, Ercilla MB, Correa LR, Ahren B, Overweight is associated with lower serum leptin in Peruvian Indian than in Caucasian women: dissociation contributing to low blood pressure? Metabolism 2001;50:325-329.
20. Florez H, Ryder E, Campos G, Fernandez, Morales LM, Valbuena H, Rincon E, Gomez ME, Raleigh X. Women relatives of Hispanic patients with type 2 diabetes are more prone to exhibit metabolic disturbances. Invest Clin 1999;40:127-142.
21. Aguilar-Salinas CA, Vazquez-Chavez C, Gamboa-Maruffo R, et al. Obesity, diabetes, hypertension, and tobacco consumption in an urban adult Mexican population. Arch Med Res, 2001;32:446-453.
22. Lorenzo C, Serrano-Ríos M, Martínez-Larrad MT, et al. Central adiposity determines prevalence differences of the metabolic syndrome. Obes Res 2003;11: 1480-1487.
23. Reaven GM. Insulin resistance, cardiovascular disease, and the metabolic syndrome: how well do the emperor's clothes fit? Diabetes Care 2004;27:1011-1012.
24. Perez F, Carrasco E, Santos JL, Calvillan M, Albala C, [Prevalence of obesity, hypertension and dyslipidemia in rural aboriginal groups in Chile] [in Spanish]. Rev Med Chil 1999;127:1169-1175.
25. Lorenzo C, Serrano-Rios M, Martinez Larrad MT, et al. Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes mellitus in Mexican-origin populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study. Diabetes Care 2001;24:2059-2064.
26. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, et al. Prevalence of hypertension in Hispanic and non-Hispanic white populations. Hypertension 2002;39:203-208.